Based on the provided data, I would recommend a HOLD for the stock. Here's a brief justification:

* The high trailing PE (59.16928) and forward PE (80.20538) suggest that the stock is trading at a premium, which might indicate that the market has already factored in the company's growth prospects. This could limit the upside potential in the short term.
* The ROE (0.18792) is decent, indicating that the company is generating reasonable returns on its equity.
* The profit margin (0.10831001) is relatively low, which could be a concern, especially in a competitive industry like specialty chemicals.
* The negative revenue growth (-0.033) and earnings growth (-0.449) are significant red flags, indicating that the company is facing challenges in terms of top-line and bottom-line expansion.
* The debt-to-equity ratio (11.418) is relatively high, which could increase the company's risk profile and make it more vulnerable to economic downturns.

Overall, while the company's fundamentals are not extremely weak, the high valuation multiples, negative growth rates, and high debt-to-equity ratio suggest that a HOLD rating is more appropriate at least until the company can demonstrate a turnaround in its growth trajectory and improve its financial performance.